论文部分内容阅读
目的:对重症监护病房(ICU)患者输血治疗的临床效果进行分析。方法:选取本院2013年5月至2015年1月收治的60例ICU患者进行分析,通过输血治疗后,分析其治疗后好转率、死亡率和治疗前后血小板、凝血酶时间、部分凝血活酶时间、凝血酶原时间、纤维蛋白原变化情况。结果:60例ICU患者通过输血治疗后好转率为78.3%,死亡率为21.7%;患者实施临床治疗后血小板、凝血酶时间和纤维蛋白原均显著高于治疗前的,治疗后部分凝血活酶时间、凝血酶原时间显著低于治疗前,差异具有统计学意义(P<0.05)。结论:输血治疗可有效改善ICU患者临床症状,在短时间内补充危急重症患者血容量,改善其循环状况,保障患者安全。
Objective: To analyze the clinical effect of blood transfusion in intensive care unit (ICU) patients. Methods: Sixty ICU patients admitted from May 2013 to January 2015 in our hospital were analyzed. After transfusion, the rate of improvement, mortality, platelet count, thrombin time, partial thromboplastin Time, prothrombin time, changes in fibrinogen. Results: The improvement rate of transfusion after 60 ICU patients was 78.3% and the mortality rate was 21.7%. The platelet, thrombin time and fibrinogen in patients after clinical treatment were significantly higher than those before treatment. After treatment, the partial thromboplastin Time, prothrombin time was significantly lower than before treatment, the difference was statistically significant (P <0.05). CONCLUSION: Transfusion therapy can effectively improve the clinical symptoms of patients with ICU, replenish the blood volume of critically ill patients within a short period of time, improve their circulatory status and ensure the safety of patients.